Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282000690> ?p ?o ?g. }
- W4282000690 endingPage "1156" @default.
- W4282000690 startingPage "1156" @default.
- W4282000690 abstract "The epidermal growth factor receptor (EGFR) is highly expressed in many non-small cell lung cancers (NSCLC), necessitating the use of EGFR-tyrosine kinase inhibitors (TKIs) as first-line treatments. Osimertinib (OSM), a third-generation TKI, is routinely used in clinics, but T790M mutations in exon 20 of the EGFR receptor lead to resistance against OSM, necessitating the development of more effective therapeutics. Telmisartan (TLM), OSM, and cell cycle and apoptosis regulatory protein 1 (CARP-1) functional mimetic treatments (CFM4.17) were evaluated in this study against experimental H1975 tumor xenografts to ascertain their anti-cancer effects. Briefly, tumor growth was studied in H1975 xenografts in athymic nude mice, gene and protein expressions were analyzed using next-generation RNA sequencing, proteomics, RT-PCR, and Western blotting. TLM pre-treatment significantly reduced the tumor burden when combined with CFM-4.17 nanoformulation and OSM combination (TLM_CFM-F_OSM) than their respective single treatments or combination of OSM and TLM with CFM 4.17. Data from RNA sequencing and proteomics revealed that TLM_CFM-F_OSM decreased the expression of Lamin B2, STAT3, SOD, NFKB, MMP-1, TGF beta, Sox-2, and PD-L1 proteins while increasing the expression of AMPK proteins, which was also confirmed by RT-PCR, proteomics, and Western blotting. According to our findings, the TLM_CFM-F_OSM combination has a superior anti-cancer effect in the treatment of NSCLC by affecting multiple resistant markers that regulate mitochondrial homeostasis, inflammation, oxidative stress, and apoptosis." @default.
- W4282000690 created "2022-06-13" @default.
- W4282000690 creator A5005750588 @default.
- W4282000690 creator A5011562879 @default.
- W4282000690 creator A5032484150 @default.
- W4282000690 creator A5032627172 @default.
- W4282000690 creator A5037848795 @default.
- W4282000690 creator A5044395046 @default.
- W4282000690 creator A5044520904 @default.
- W4282000690 creator A5059706529 @default.
- W4282000690 creator A5062436057 @default.
- W4282000690 creator A5063691131 @default.
- W4282000690 creator A5077688363 @default.
- W4282000690 creator A5079096229 @default.
- W4282000690 creator A5088547350 @default.
- W4282000690 date "2022-05-28" @default.
- W4282000690 modified "2023-10-06" @default.
- W4282000690 title "Combined Transcriptomic and Proteomic Profiling to Unravel Osimertinib, CARP-1 Functional Mimetic (CFM 4.17) Formulation and Telmisartan Combo Treatment in NSCLC Tumor Xenografts" @default.
- W4282000690 cites W117291004 @default.
- W4282000690 cites W1546552389 @default.
- W4282000690 cites W1563676220 @default.
- W4282000690 cites W1581923494 @default.
- W4282000690 cites W1883752949 @default.
- W4282000690 cites W1892589479 @default.
- W4282000690 cites W1952001103 @default.
- W4282000690 cites W1984601093 @default.
- W4282000690 cites W1990278643 @default.
- W4282000690 cites W1994041994 @default.
- W4282000690 cites W1996165533 @default.
- W4282000690 cites W1996308257 @default.
- W4282000690 cites W2001547191 @default.
- W4282000690 cites W2005433820 @default.
- W4282000690 cites W2008386237 @default.
- W4282000690 cites W2012047645 @default.
- W4282000690 cites W2024492396 @default.
- W4282000690 cites W2031332374 @default.
- W4282000690 cites W2038024670 @default.
- W4282000690 cites W2045387133 @default.
- W4282000690 cites W2052414359 @default.
- W4282000690 cites W2062289724 @default.
- W4282000690 cites W2067339755 @default.
- W4282000690 cites W2074688366 @default.
- W4282000690 cites W2074894911 @default.
- W4282000690 cites W2090966736 @default.
- W4282000690 cites W2092338119 @default.
- W4282000690 cites W2095618958 @default.
- W4282000690 cites W2097795961 @default.
- W4282000690 cites W2099257830 @default.
- W4282000690 cites W2101569260 @default.
- W4282000690 cites W2102748761 @default.
- W4282000690 cites W2102891343 @default.
- W4282000690 cites W2103960475 @default.
- W4282000690 cites W2105605511 @default.
- W4282000690 cites W2115750021 @default.
- W4282000690 cites W2122636101 @default.
- W4282000690 cites W2125212422 @default.
- W4282000690 cites W2129360604 @default.
- W4282000690 cites W2137816700 @default.
- W4282000690 cites W2143914234 @default.
- W4282000690 cites W2146418087 @default.
- W4282000690 cites W2155786065 @default.
- W4282000690 cites W2159620999 @default.
- W4282000690 cites W2162324757 @default.
- W4282000690 cites W2168215091 @default.
- W4282000690 cites W2171176373 @default.
- W4282000690 cites W2171370330 @default.
- W4282000690 cites W2179438025 @default.
- W4282000690 cites W2180481128 @default.
- W4282000690 cites W2340789820 @default.
- W4282000690 cites W2361876374 @default.
- W4282000690 cites W2378788102 @default.
- W4282000690 cites W2429716030 @default.
- W4282000690 cites W2509808024 @default.
- W4282000690 cites W2538689707 @default.
- W4282000690 cites W2548539834 @default.
- W4282000690 cites W2608688777 @default.
- W4282000690 cites W2625117911 @default.
- W4282000690 cites W2726161792 @default.
- W4282000690 cites W2746286236 @default.
- W4282000690 cites W2751913107 @default.
- W4282000690 cites W2755551407 @default.
- W4282000690 cites W2768499221 @default.
- W4282000690 cites W2788367934 @default.
- W4282000690 cites W2789907012 @default.
- W4282000690 cites W2791297317 @default.
- W4282000690 cites W2809478731 @default.
- W4282000690 cites W2810955489 @default.
- W4282000690 cites W2892305313 @default.
- W4282000690 cites W2935024989 @default.
- W4282000690 cites W2967842374 @default.
- W4282000690 cites W2972291002 @default.
- W4282000690 cites W2976334328 @default.
- W4282000690 cites W2993608316 @default.
- W4282000690 cites W3009963727 @default.
- W4282000690 cites W3025480760 @default.
- W4282000690 cites W3043034208 @default.
- W4282000690 cites W3047972876 @default.
- W4282000690 cites W3087992083 @default.